Back to Newsroom

Novavax Announces Closing of Public Offering

GAITHERSBURG, Md., April 16, 2018 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases, today announced the closing of the underwritten public offering priced on Wednesday, April 11, 2018.
READ MORE…